Prioritize Effectiveness Over Side Effects

Medications like Dinepazil may show statistical benefits in studies, but their clinical efficacy is questionable and not substantial from the patient's perspective. The potential harm, including significant side effects like gastrointestinal issues and bradycardia, can outweigh the marginal benefits. These medications should not be the primary treatment focus, as they offer minimal meaningful improvement and can complicate patient care, particularly for those with existing health vulnerabilities.